-
Cy5 NHS ester(Et): Practical Labeling Guide
2026-09-15
Cy5 NHS ester(Et) is an amine-reactive fluorescent dye for covalently tagging proteins, peptides, and other biomolecules in workflows such as immunofluorescence staining, flow cytometry, and fluorescence microscopy. It is suitable for aqueous or DMSO-assisted preparation but should not be used in ethanol-based protocols or retained as a long-term working solution.
-
Chloroquine Diphosphate in Ferroptosis Translation
2026-09-15
A translational framework for using Chloroquine diphosphate as a mechanistic autophagy and cell-cycle perturbation alongside the DGLA–ACSL4 ferroptosis axis in acute myeloid leukemia research.
-
Saracatinib (AZD0530): From Src Biology to Translation
2026-09-14
Saracatinib (AZD0530) offers a mechanism-led framework for studying Src/Abl signaling across cancer models, while carefully bounded analysis of Reelin–SFK biology reveals how pathway context can guide translational assay design.
-
SORL1 Deficiency Reshapes Neuronal and Microglial ELN
2026-09-14
Mishra, Jayadev, and Young synthesize evidence that SORL1 deficiency disrupts different compartments of the endo-lysosomal network in human neurons and microglia. Their cell-type-specific interpretation highlights why human induced pluripotent stem cell models are valuable for connecting Alzheimer’s disease risk genes with therapeutic mechanisms.
-
Dacomitinib (PF-00299804) Assay Guide
2026-09-13
A scenario-based guide to using Dacomitinib (PF-00299804), SKU A8319, in viability, proliferation, cytotoxicity, and exploratory ferroptosis studies. It connects reported pan-HER potency with practical controls, formulation handling, interpretation limits, and vendor-selection considerations.
-
Tianhuang Formula, RAGE/POMC, and Berberine
2026-09-12
A 2026 pre-proof study identifies RAGE as a central nervous system target of berberine within Tianhuang Formula and links RAGE/POMC signaling to hypothalamic neuronal apoptosis, autophagy, and glucolipid regulation. Its integrated computational, cellular, and mouse-model design offers a mechanistic framework for metabolic research, although causal validation, dosing, and clinical translation remain unresolved.
-
Halazone and Sodium Current Inactivation in Frog Nerve
2026-09-12
The reference study used voltage-clamped frog nerve fibers to compare Halazone with chemically distinct oxidants and residue-reactive reagents. Its central finding was that Halazone and hypochlorous acid strongly reduced sodium-current inactivation, challenging a simple methionine-centered explanation and implicating membrane-lipid modification as a plausible alternative.
-
Halazone: From Water Disinfection to Ion-Channel Insight
2026-09-11
Halazone is more than a conventional water disinfection agent: its HOCl-generating chemistry supports rapid bactericidal action, while electrophysiology findings reveal a distinct route to sodium-channel modulation. This thought-leadership analysis translates those mechanisms into practical guidance for antimicrobial resistance research, neurophysiology, and translational assay design.
-
Reserpine N1867: Practical Lab QC Guide
2026-09-11
Reserpine (SKU N1867) provides a characterized research reagent for neurotransmitter depletion research, antihypertensive mechanism studies, and neuropharmacology workflows. This guide covers identity checks, DMSO preparation, storage, and failure prevention; it is not intended to support diagnostic, therapeutic, or medical use.
-
Tamsulosin Workflows for Urological Research
2026-09-10
Build reproducible Tamsulosin assays for α1A-linked smooth muscle relaxation, ureteral stone passage, and postoperative urinary retention models. This guide translates meta-analytic evidence into practical concentration, handling, endpoint, and troubleshooting decisions for translational laboratories.
-
USP42, JNK/p38 Signaling, and Breast Cancer Apoptosis
2026-09-10
The reference study identifies USP42 as a pro-tumorigenic deubiquitinating enzyme that supports breast cancer cell survival by suppressing JNK/p38-associated apoptosis. Its integrated cell-based, pathway-inhibitor, and xenograft experiments provide a preclinical framework for evaluating USP42 as a potential therapeutic target while highlighting important limits in mechanistic and clinical validation.
-
Magnetic Stimulation Targets GABRE in Schizophrenia
2026-09-09
This Molecular Psychiatry study identifies the GABAA receptor ε subunit, encoded by Gabre, in the left prelimbic cortex as a mechanistically actionable target for schizophrenia-like behaviors in mice. By combining focal magnetic stimulation with loss- and gain-of-function experiments, the authors connect GABRE regulation to synaptic abnormalities and suggest a p62/SQSTM1–GABARAP pathway that may support therapeutic modulation.
-
MLKL–Lysosome Crosstalk in Necroptosis
2026-09-09
The reference study identifies MLKL polymerization-induced lysosomal membrane permeabilization as a critical execution step in necroptosis. Its imaging, pharmacological, and genetic evidence places lysosomal cathepsin B release upstream of lethal cellular damage and provides a framework for testing lysosomal protease dependence in regulated cell death.
-
Nintedanib (BIBF 1120) in Precision Oncology
2026-09-08
Nintedanib (BIBF 1120) combines VEGFR, FGFR, and PDGFR blockade in one research tool for modeling angiogenesis, tumor signaling, and fibrosis. This guide translates its target profile into ATRX-aware glioma assays, practical dosing workflows, and troubleshooting strategies.
-
LKB1, Histone Lactylation, and Senescence in Lung Cancer
2026-09-07
The reference study identifies a mechanistic link between LKB1 loss, telomerase activation, and lung adenocarcinoma senescence through Sp1-dependent TERT transcription and histone lactylation. Its findings support combining telomerase inhibition with glycolysis-directed treatment, while also highlighting the need to validate this pathway across genetically diverse tumor models.